This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Caryn Lerman, PhD; Robert Croyle, PhD

Arch Intern Med. 1994;154(6):609-616.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS ESTIMATED that approximately 180 000 American women developed breast cancer in 1993, and 46 000 of these women died of this disease.¹ Recent work in molecular genetics has led to the identification of genes that confer susceptibility to breast cancer, including a major breast—ovarian cancer susceptibility gene on chromosome 17.^2-5 As many as one in 300 women may carry germline mutations on one or more breast cancer susceptibility genes.⁶

These advances bring promise of clinical genetic testing for breast cancer susceptibility. In a few settings, this information already is being applied to identify gene carriers and noncarriers within families with hereditary breast cancer.^7,8 As yet, however, there are no guidelines for communicating genetic information about breast cancer susceptibility or for providing recommendations and follow-up care for identified gene carriers. This is a serious concern, as previous research suggests that cancer risk notification can have . . . [Full Text PDF of this Article]

Author Affiliations
Lombarde Cancer Research Center Georgetown University School of Medicine 2233 Wisconsin Ave Suite 210 Washington, DC 20007; Department of Psychology University of Utah Salt Lake City, UT 84132

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?